JP2010265270A5 - - Google Patents

Download PDF

Info

Publication number
JP2010265270A5
JP2010265270A5 JP2010130101A JP2010130101A JP2010265270A5 JP 2010265270 A5 JP2010265270 A5 JP 2010265270A5 JP 2010130101 A JP2010130101 A JP 2010130101A JP 2010130101 A JP2010130101 A JP 2010130101A JP 2010265270 A5 JP2010265270 A5 JP 2010265270A5
Authority
JP
Japan
Prior art keywords
base sequence
tumor cells
seq
bases
double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010130101A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010265270A (ja
JP5377416B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010130101A priority Critical patent/JP5377416B2/ja
Priority claimed from JP2010130101A external-priority patent/JP5377416B2/ja
Publication of JP2010265270A publication Critical patent/JP2010265270A/ja
Publication of JP2010265270A5 publication Critical patent/JP2010265270A5/ja
Application granted granted Critical
Publication of JP5377416B2 publication Critical patent/JP5377416B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010130101A 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法 Expired - Fee Related JP5377416B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010130101A JP5377416B2 (ja) 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004192718 2004-06-30
JP2004192718 2004-06-30
JP2010130101A JP5377416B2 (ja) 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006528503A Division JP4771950B2 (ja) 2004-06-30 2005-06-20 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法

Publications (3)

Publication Number Publication Date
JP2010265270A JP2010265270A (ja) 2010-11-25
JP2010265270A5 true JP2010265270A5 (enExample) 2011-07-07
JP5377416B2 JP5377416B2 (ja) 2013-12-25

Family

ID=35782615

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006528503A Expired - Fee Related JP4771950B2 (ja) 2004-06-30 2005-06-20 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法
JP2010130102A Pending JP2010270119A (ja) 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法
JP2010130101A Expired - Fee Related JP5377416B2 (ja) 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006528503A Expired - Fee Related JP4771950B2 (ja) 2004-06-30 2005-06-20 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法
JP2010130102A Pending JP2010270119A (ja) 2004-06-30 2010-06-07 腫瘍細胞増殖を抑制するオリゴヌクレオチド及び方法

Country Status (4)

Country Link
US (1) US20080280359A1 (enExample)
EP (1) EP1785484B1 (enExample)
JP (3) JP4771950B2 (enExample)
WO (1) WO2006003804A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2148097B1 (en) 2007-05-11 2016-01-06 Chuo University Fluid pouring type actuator
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
WO2022140261A1 (en) * 2020-12-22 2022-06-30 Ambys Medicines, Inc. Biliary delivery methods, compositions and kits for use therein
CN116716302B (zh) * 2023-08-03 2023-11-10 上海懿贝瑞生物医药科技有限公司 一种用于降低食管癌细胞中nek2基因表达的核酸分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003144168A (ja) 2001-11-14 2003-05-20 National Institute Of Infectious Diseases 核外移行機能又は核−細胞質間移行機能を有する細胞周期関連タンパク質
US20040019003A1 (en) 2002-01-24 2004-01-29 Chiron Corporation Nek2 inhibitors
US8252520B2 (en) * 2002-10-11 2012-08-28 Taivex Therapeutics Corporation Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers

Similar Documents

Publication Publication Date Title
NZ607870A (en) Lactococcus crispr-cas sequences
WO2012075040A3 (en) mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
WO2008043521A3 (de) Microrna (mirna) zur diagnose und therapie von herzerkrankungen
JP2014054250A5 (enExample)
MX2013009191A (es) Oligonucleotidos antisentido.
JP2010500029A5 (enExample)
WO2012078536A3 (en) Double stranded oligonucleotide compounds comprising threose modifications
JP2012136542A5 (enExample)
AR079881A1 (es) Plantas tolerantes a herbicidas inhibidores de las hppd
HK1203075A1 (en) Substituted phosphorothioate nucleotide analogs
JP2013510561A5 (enExample)
JP2015142558A5 (enExample)
HK1209781A1 (en) Oligonucleotide-based inhibitors comprising locked nucleic acid motif
AR079883A1 (es) Plantas tolerantes a herbicidas inhibidores de las hppd
EA201290572A1 (ru) Растения, устойчивые к гербицидам - ингибиторам hppd
TR201815882T4 (tr) Tal efektörü aracılı dna modifikasyonu.
NZ607996A (en) Substituted nucleotide analogs
NZ598557A (en) Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
JP2010523099A5 (enExample)
JP2012503478A5 (enExample)
NZ700902A (en) Lowering saturated fatty acid content of plant seeds
JP2011177189A5 (enExample)
JP2014530803A5 (enExample)
JP2010088434A5 (enExample)
MX362061B (es) Ácidos nucleicos de enlace c5a nuevos.